Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Pluvia's Fist.com - Pluvia's Plays & Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Pluvia who wrote (1661)	11/15/2004 7:45:35 PM
From: Dan B.	Respond to of 1766

Pardon me folks, but I can only say "the scum also rises." EOM Dan B.

To: Pluvia who wrote (1661)	2/1/2006 5:40:01 PM
From: Pluvia	Read Replies (1) \| Respond to of 1766

VSGN hit $3.00 today, we suggested buying VSGN at 1.90-2.05 on 9/2/2005; Message 21664681 We see VSGN as an excellent opportunity for a trading position going into Phase III CHF treatment results; we expect excellent results from that study. We believe another, perhaps BETTER way to capitalize on VSGN results is to own LVRO. We like LVRO technology, capitalization and disease selection better than VSGN. We will issue a report comparing LVRO vs VSGN shortly...